SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

Hotter-than-expected inflation has fueled concern about further Fed rate hikes, weighing on rate-sensitive Nasdaq stocks; traders also point to worries about AI spending and financing as amplifying the tech selloff. The community is split between calling it a broader AI-driven correction and looking for an oversold bounce, with upcoming economic data and TSMC results seen as potential catalysts.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

A broad selloff in SPY has traders focused on hotter-than-expected inflation and the risk of a more hawkish Fed, with AI-sector worries adding to pressure. Bears see room for further declines, while some traders argue the drop is overdone and expect a relief bounce; upcoming PPI is another focus.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

Gartners warning that most independent neocloud providers may not survive as AI infrastructure spending outpaces revenue has intensified concerns about CoreWeaves debt-heavy expansion and sharply rising bond yields. Traders are debating whether financing risks threaten the business or whether its large contract backlog and continuing AI demand make the selloff overdone.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius is falling with neocloud and AI infrastructure stocks as traders react to Gartners warning that most independent neocloud providers may not remain independent by 2030, alongside concerns about financing costs and hot inflation. The selloff has sparked debate between investors viewing it as a sector-wide valuation reset and dip-buying opportunity, and those worried that capital-intensive AI buildouts may outpace returns.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Hotter-than-expected U.S. inflation and higher-rate concerns are weighing on NVDA alongside a broader tech and semiconductor selloff; traders are also questioning whether AI spending can justify valuations, citing debt-financed neocloud customers and potential circular financing. Bearish traders expect further weakness, while dip-buyers argue that AI-chip demand remains strong and view the pullback as an opportunity.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracles steep selloff is drawing attention amid a broader AI-infrastructure downturn, with traders citing hotter-than-expected inflation and rate concerns alongside worries about Oracles heavy data-center spending, debt and exposure to AI customers. Some see the drop as an overreaction and are buying the dip, while others expect further downside as financing and demand risks persist.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

A sharp semiconductor selloff has weighed on SOXL amid fears about Chinese chip competition, AI spending and profitability, and inflation; the funds 3x leverage is amplifying the swings. Traders disagree on whether the decline is an overreaction to strong chip demand or a sign of further downside, with dip-buyers facing off against bearish sellers.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN is selling off with other neocloud and AI data-center stocks as traders react to Gartners warning that infrastructure spending may outpace AI revenue, alongside inflation and financing concerns. Bulls view the decline as a buying opportunity, while bears question the sectors economics; speculation about Anthropic-related news is also circulating.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

The FDA expanded Anktivas use to include BCG-unresponsive, high-grade papillary-only bladder cancer, broadening the eligible patient population ahead of the expected decision date. Traders generally view the label expansion as a meaningful commercial and regulatory positive, but many are frustrated by the muted share-price reaction and debate whether the approval was already priced in or the stock is facing selling pressure.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Cloud Memory Business Unit (CMBU), Core Data Center Business Unit (CDBU), Mobile and Client Business Unit (MCBU), and Automotive and Embedded Business Unit (AEBU). The CMBU segment focuses on memory solutions for large hyperscale cloud customers and High-Bandwidth Memory for all data center customers. The CDBU segment is involved in memory solutions for mid-tier cloud, enterprise, and OEM data center customers and storage solutions for all data center customers. The MCBU segment focuses on memory and storage solutions for the mobile and client segments. The AEBU segment is involved in memory and storage solutions for the automotive, industrial, and consumer segments. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

A sharp selloff across memory and AI-linked chip stocks has put MU in focus, with traders citing hotter inflation and rate concerns, doubts about AI spending and profitability, profit-taking, and competitive pressure from Chinas CXMT. Bulls argue that strong AI-memory demand and Microns fundamentals remain intact, while bears see the decline as part of a broader unwind of the AI trade.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Can-Fite’s Liver Cancer Trial Just Got More Interesting and the FDA Clock Matters Now

Can-Fite BioPharma (NYSEAMERICAN:CANF) has put a potentially important new marker on the radar for its late-stage liver-cancer program: patients in the company’s ongoing pivotal Phase III study of Namodenoson are living longer than anticipated across the blinded study population.

AI, Clinical Data, and Regulatory Catalysts have Wall Street Watching These Biotechs

Three emerging biotechnology companies, Can-Fite BioPharma (NYSEAMERICAN:CANF), NeOnc Technologies (NASDAQ:NTHI), and PMGC Holdings (NASDAQ:ELAB) through its NorthStrive Biosciences subsidiary, are pursuing a distinct therapeutic strategy, the common theme is execution. Clinical data, regulatory milestones, AI-assisted discovery platforms, and expanding development pipelines are creating a steady stream of catalysts that investors will be watching closely during the second half of 2026.

Why Is CANF Stock Surging Today?

Equity

Can-Fite said Namodenoson met the Phase IIa study's main safety goal and demonstrated durable overall survival.

CANF Stock Pulls Back After Patent-Fueled Surge – Retail Calls It Consolidation Ahead Of Next Leg Up

Can-Fite BioPharma announced it has received a patent in Japan for its obesity therapy.

CANF Stock Soars 20% on Positive Mid-Stage Pancreatic Cancer Data

Can-Fite stock jumps 20% after mid-stage data show namodenoson is well tolerated in advanced pancreatic cancer patients, meeting the study's primary safety endpoint.

Power, Compute and Breakthrough Science

Today’s headlines underscore a decisive shift toward owning the infrastructure, power, and materials that will underpin the next phase of the AI economy, including $KBLB, $VCIG, $CANF, $ASNS, $BW, and $APLD

Why Did CANF Stock Soar 25% Today?

The company said its trial to study the treatment of patients with advanced pancreatic ductal adenocarcinoma met its primary endpoint.

This Microcap Just Locked Up New IP in a Massive Pharma Market

In biotechnology, intellectual property wins often act as quiet but powerful catalysts, particularly when they extend a platform into new therapeutic categories or unlock access to large international markets. As competition intensifies and pipelines mature, patent protection remains a key driver of long-term value, especially for companies advancing novel mechanisms with broad clinical applicability.Shares of Can-Fite BioPharma Ltd. (NYSE American: CANF) are surging Friday after the company announced it was granted a new patent in Brazil covering the treatment of sexual dysfunction. The ...

Can-Fite BioPharma Ltd. is a biopharmaceutical company, which engages in the development of drugs for the treatment of cancer, liver and inflammatory diseases and erectile dysfunction. Its product pipeline include Piclidenoson, Namodenoson, and CF602. The company was founded by Pnina Fishman and Ilan Cohn on September 11, 1994 and is headquartered in Petach-Tikva, Israel.

Can-Fite Biopharma Ltd - ADR

Bullish Sentiment

Hotter than expected

As expected

Cooler than expected

The September Producer Price Index report lands Thursday, October 15 at 8:30 AM ET, one day after CPI, with August’s reading at 5.4% year over year, as investors look for clues on inflation before the Fed’s October 27-28 meeting. How will the September PPI print compare to consensus expectations? Vote and explain your reasoning in the comments.

How will the September PPI print compare to consensus expectations?

Current Price	$1.93
Prev Close	$1.95
Open	$1.95
Dividend Yield	0.00%
50-Day Moving Average	$2.68
Beta	0.59
Avg. Volume	1.04M
PE Ratio	-0.31

52-Week High	$12.30
52-Week Low	$1.90
Market Capitalization	$5.91M
EPS (Annual)	-$12.03
Price to Book	0.86
Revenue Per Employee	$81,642.60

Feed

News

Sentiment

Fundamentals

Info

CANF Fundamentals